{
  "count": 1,
  "data": [
    {
      "id": "baseimmune",
      "name": "Baseimmune",
      "short": "Baseimmune",
      "category": "biotech",
      "founded": 2019,
      "employees": "~20",
      "funding": "$11.3M Series A",
      "funding_num_m": 11,
      "valuation": null,
      "focus": "AI-designed vaccines · predicts pathogen mutations · cross-protective synthetic antigens",
      "ethos": "Future-proof vaccines",
      "hq": "King's Cross (LBIC Apex Building)",
      "key_people": null,
      "milestones": null,
      "founders": null,
      "careers_url": null,
      "created_at": "2026-03-11T13:13:53.429371+00:00",
      "updated_at": "2026-03-11T13:13:53.429371+00:00",
      "ch_number": null,
      "github_org": null,
      "website_url": "https://baseimmune.com",
      "twitter": null,
      "linkedin_url": null,
      "logo_url": "https://logo.clearbit.com/baseimmune.com",
      "tags": [
        "biotech",
        "health",
        "vaccines"
      ],
      "description": "Baseimmune. AI-designed vaccines targeting rapidly mutating viruses. Deep learning platform predicts future pathogen mutations to create cross-protective synthetic antigens. Oxford Jenner Institute spinout. Vaccines in preclinical for ASF, coronavirus, malaria. Tags: biotech, health, vaccines",
      "clients": "Pharma partners (vaccine development), animal health"
    }
  ]
}